Clinical Trial Update: GLEAM: Noninvasive Glucose Measurement Using Impedance Tomography [NA]

View source ↗

Summary

The GLEAM trial evaluating noninvasive glucose measurement using impedance tomography in diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Diabetes Mellitus | NA | Status: COMPLETED